Browns owners Dee and Jimmy Haslam have donated $12.5 million toward blood cancer research and treatment, the team announced Wednesday.
Donation Breakdown
The donation includes $10 million to the Oxford-Harrington Rare Disease Centre in England for research and drug development focused on chronic lymphocytic leukemia (CLL) and other rare blood cancers. The remaining $2.5 million will go to Cleveland's University Hospitals Seidman Cancer Center, which will establish an endowed chair in CLL research and an innovation fund to drive advancements in care.
Personal Connection
Dee Haslam was diagnosed with CLL in 2021. "I am extremely grateful that I am living a full, healthy life after being diagnosed with CLL in 2021," she said in a statement. "Together with UH Seidman Cancer Center and the Oxford-Harrington Centre, we hope to increase knowledge of CLL, generate new treatments and give others the confidence and information they need to navigate the disease. Ideally, cures for other blood disorders will be discovered in the process."
About CLL
CLL is the most common form of leukemia in adults. While there is no cure, modern therapies have made it a manageable condition.
Harrington Discovery Institute
The Harrington Discovery Institute, founded in 2021, has 227 medicines in development, supported 75 institutions, launched 47 companies, has 24 medicines in clinical trials, and 15 licenses to pharmaceutical companies.
The Haslams are also majority owners of the Milwaukee Bucks, Major League Soccer's Columbus Crew, and an NWSL expansion franchise in Columbus.
